Cargando…
Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer Cells
Many key actions of ω-3 (n-3) fatty acids have recently been shown to be mediated by two G protein-coupled receptors (GPCRs) in the free fatty acid receptor (FFAR) family, FFA1 (GPR40) and FFA4 (GPR120). n-3 Fatty acids inhibit proliferation of human breast cancer cells in culture and in animals. In...
Autores principales: | Hopkins, Mandi M., Zhang, Zhihong, Liu, Ze, Meier, Kathryn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773772/ https://www.ncbi.nlm.nih.gov/pubmed/26821052 http://dx.doi.org/10.3390/jcm5020016 |
Ejemplares similares
-
MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021) -
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017) -
Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018) -
Role of lysophosphatidic acid in proliferation and differentiation of intestinal epithelial cells
por: Konno, Tasuku, et al.
Publicado: (2019)